News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dr. John Crew Gives Grand Rounds Presentation On Treating Wounds With NovaBay Pharmaceuticals, Inc. (NBY)'s Neutrophase At Eisenhower Medical Center



2/6/2014 9:36:02 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EMERYVILLE, Calif., Feb. 6, 2014 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a clinical-stage biopharmaceutical company developing topical non-antibiotic anti-microbial products, today announced that Dr. John R. Crew, MD,FACS, Vascular Surgeon, Medical Director, Advanced Wound Care Center, Seton Medical Center in Daly City, California, will explain to medical staff at Eisenhower Medical Center in Palm Springs, California, how NeutroPhase®* wound cleanser can help manage the severely-infected wounds of patients with life-threatening 'flesh-eating' disease. NeutroPhase is a 0.01% pure hypochlorous acid in saline with no bleach impurities, unlike Dakin and other Dakin-like solutions.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES